Roche coy on job cut reports
September 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts
Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
Paul Phull joins PharmaVentures
August 31, 2010Sales and Marketing PharmaVentures, appointment, sales and marketing
Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …
Swiss approval for Novartis’ Tasigna
August 31, 2010Sales and Marketing Novartis, Tasigna, Tekamlo
Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …
Sanofi’s $18.5bn bid for Genzyme rejected
August 31, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
Lonza buys Vivante to get bigger in biologics
August 31, 2010Manufacturing and Production Lonza, Vivante
Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …
Swiss API manufacturer opens high-potency plant
August 31, 2010Manufacturing and Production API, Cerbios-Pharma
Cerbios-Pharma SA of Switzerland has officially opened its new high-potency active pharmaceutical ingredient manufacturing plant in Barbengo, a district in …
Hyaluron pulled up over particle contamination
August 31, 2010Manufacturing and Production Hyaluron, manufacturing compliance
US manufacturer Hyaluron has been sent a warning letter by the FDA after a routine inspection uncovered concerns with aseptic …
SOCMA welcomes US law easing raw material imports
August 27, 2010Manufacturing and Production Obama, SOCMA
US President Barack Obama has signed into law the Manufacturing Enhancement Act of 2010, designed to do away with import …
Chandler Chicco expands European services with Wright appointment
August 27, 2010Medical Communications Chandler Chicco, Cohn & Wolfe, Europe
Chandler Chicco has appointed Alison Wright to a newly created post to help increase the agency’s European and global services …
US prescription drug prices rise above inflation
August 27, 2010Sales and Marketing US, prices
A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …
US court bars stem cell funding
August 26, 2010Sales and Marketing Obama, Stem cells, US
A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …
CMC Bio unveils disposable biomanufacturing facility
August 26, 2010Manufacturing and Production CMC Biologics, disposables
Contract manufacturer CMC Biologics has completed the construction of a new manufacturing facility at its site in Bothell near Seattle …
J&J chalks up ninth product recall in 2010
August 26, 2010Manufacturing and Production J&J, JJ
Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …
Alcon acquisition makes Novartis eyecare leader
August 26, 2010Sales and Marketing Novartis, ophthalmology
Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …
Janssen to appeal against Velcade decision
August 26, 2010Medical Communications, Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma
Celgene’s Thalidomide has been recommended by NICE for multiple myeloma ahead of Janssen-Cilag’s Velcade. A final appraisal determination says that …
NICE updates guidance for arthritis treatments
August 26, 2010Sales and Marketing NICE, Roche, rheumatoid arthritis
Five new drugs for rheumatoid arthritis have been given the thumbs up by NICE as second line treatment. Roche’s MabThera, …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2
August 26, 2010Research and Development Kinapse, White paper, life sciences, pharma
With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Multaq given limited approval from NICE
August 25, 2010Medical Communications, Sales and Marketing Multaq, NICE, Sanofi-Aventis, atrial, dronedarone
NICE has given a restricted approval to Sanofi-Aventis’s Multaq as a second line treatment for atrial fibrillation patients. The guidance …
Avastin patient access scheme too complicated, says NICE
August 25, 2010Sales and Marketing NICE, avastin, patient access
NICE is set to say no again to Avastin for use in patients with colorectal cancer. Avastin was first launched …
Roche signs $1bn peptide deal with Aileron
August 25, 2010Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics
Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
